Study of RO7763505 in healthy people and stable heart disease
Part of Heart & circulation clinical trials.
This study tests an experimental drug (RO7763505) in healthy people and people with stable heart disease. It aims to see how safe the drug is and how it works in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are generally healthy or have stable heart disease that hasn't changed in the past 3 months
- If you have heart disease: you have had a heart attack before and have a clear image (like a CT scan) showing blocked arteries
- You don't have severe heart failure (NYHA class III or IV)
- You haven't had a vaccine in the last 28 days (except a flu shot 14 days ago)
- You don't have a weakened immune system
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.
This early-phase trial tests a new drug called RO7875913 in healthy volunteers to find the safest dose. It helps researchers understand how the drug works in the body before moving to studies in people with the disease.
This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.
This is an early-stage safety test of a new experimental drug called HRS-5765 in people without serious health conditions. Researchers want to make sure the drug is safe and understand how your body processes it.
This is an early-stage safety study of an experimental drug called HRS-7156 in people with no serious health conditions. Researchers will monitor how your body tolerates the drug and how it moves through your system.
This trial tests a new medicine called UDP-003 in two groups: healthy volunteers and people who had a heart event (acute coronary syndrome) at least a year ago. The goal is to see if the drug is safe and how the body handles it, which could lead to better treatments for heart disease.
Hear when a new Stable Coronary Artery Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.